Stock Yards Bank & Trust Co. Has $520,000 Holdings in Aflac Incorporated (NYSE:AFL)

Stock Yards Bank & Trust Co. lowered its position in shares of Aflac Incorporated (NYSE:AFL) by 8.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,680 shares of the financial services provider’s stock after selling 410 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Aflac were worth $520,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Whipplewood Advisors LLC acquired a new stake in shares of Aflac during the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new position in Aflac in the 4th quarter valued at approximately $34,000. Curio Wealth LLC acquired a new position in Aflac in the 4th quarter valued at approximately $36,000. OFI Invest Asset Management acquired a new position in Aflac in the 4th quarter valued at approximately $38,000. Finally, Capital A Wealth Management LLC acquired a new position in Aflac in the 4th quarter valued at approximately $38,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL opened at $102.06 on Friday. The company’s fifty day moving average is $105.09 and its 200-day moving average is $105.53. Aflac Incorporated has a 12 month low of $86.55 and a 12 month high of $115.50. The firm has a market cap of $55.18 billion, a price-to-earnings ratio of 10.63, a price-to-earnings-growth ratio of 3.24 and a beta of 0.82. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 16.20% and a net margin of 28.76%. Aflac’s quarterly revenue was down 37.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.66 earnings per share. Equities analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were issued a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac’s dividend payout ratio is currently 36.25%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on AFL shares. Piper Sandler upped their price objective on shares of Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research note on Wednesday, April 2nd. UBS Group upped their price objective on shares of Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a research note on Wednesday, April 2nd. Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a research note on Monday, May 5th. Keefe, Bruyette & Woods upped their price objective on shares of Aflac from $104.00 to $106.00 and gave the company a “market perform” rating in a research note on Wednesday, May 7th. Finally, Morgan Stanley upped their price objective on shares of Aflac from $100.00 to $105.00 and gave the company an “equal weight” rating in a research note on Monday, May 19th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $104.93.

Insider Buying and Selling

In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the firm’s stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the sale, the director now directly owns 6,728 shares in the company, valued at $711,149.60. This trade represents a 29.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the firm’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director now owns 70,992 shares in the company, valued at $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 40,750 shares of company stock valued at $4,304,295. Company insiders own 0.90% of the company’s stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.